Mineralys Therapeutics, INC. (MLYS) — DEF 14A Filings

All DEF 14A filings from Mineralys Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Mineralys Therapeutics 2025 Annual Meeting Proxy Statement — Apr 9, 2025 Risk: low
Mineralys Therapeutics, Inc. is holding its 2025 Annual Meeting of Stockholders on May 22, 2025. The proxy statement details the proposals to be voted on, inclu
Mineralys Therapeutics, Inc. Announces Annual Meeting of Stockholders — Apr 9, 2024 Risk: low
Mineralys Therapeutics, Inc. (MLYS) filed a Proxy Statement (DEF 14A) with the SEC on April 9, 2024. Annual meeting scheduled for May 22, 2024, at 12:00 p.m. Ea

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX